Hari Prasad Kattel
Overview
Explore the profile of Hari Prasad Kattel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kattel H, Sharma S, Alfsnes K, Pathak R, Rijal K, Ghimire P, et al.
J Nepal Health Res Counc
. 2025 Feb;
22(3):608-615.
PMID: 39923176
Background: Hepatitis C infection is a major public health concern in Nepal. Epidemiological information on hepatitis C virus along with the status of co-infection with hepatitis B virus and human...
2.
Acharya J, Jha R, Gompo T, Chapagain S, Shrestha L, Rijal N, et al.
Int J Microbiol
. 2024 Oct;
2024:1094816.
PMID: 39445103
The need to address antimicrobial resistance (AMR) through a One Health (OH) approach is now well recognized. There is, however, limited guidance on how AMR surveillance should be implemented across...
3.
Shrestha P, Kattel H, Sharma S, Bista P, Basnet B, Ghimire P, et al.
JNMA J Nepal Med Assoc
. 2024 Oct;
62(271):202-206.
PMID: 39356784
Introduction: Pseudomonas aeruginosa isolates producing metallo-β-lactamase have caused nosocomial outbreaks, severe infections, and ineffective carbapenem therapy worldwide since 1991. Due to their prevalence, hospital infection control techniques are difficult. This...
4.
Raya S, Tandukar S, Kattel H, Sharma S, Sangsanont J, Sirikanchana K, et al.
Sci Total Environ
. 2024 Aug;
951:175473.
PMID: 39142413
Hepatitis A and E viruses (HAV and HEV, respectively) remain a significant global health concern despite advancements in healthcare and vaccination programs. Regular monitoring and vaccine efficacy of HAV are...
5.
Shrestha D, Manandhar S, Chalise B, Rajbhandari S, Bastola A, Bhandari P, et al.
PLoS One
. 2024 Mar;
19(3):e0299141.
PMID: 38466665
In Nepal, over 1 million individuals have tested positive for SARS-CoV-2. We sought to describe the frequency of nonrecovery from this infection at 6 months and associated symptoms. We conducted...
6.
Upadhaya S, Acharya J, Zolfo M, Nair D, Kharel M, Shrestha A, et al.
Trop Med Infect Dis
. 2023 Aug;
8(8).
PMID: 37624337
An operational research study was conducted in 2019 to assess the quality of data submitted by antimicrobial resistance (AMR) surveillance sites in the Bagmati Province of Nepal to the National...
7.
Maharjan S, Ansari M, Maharjan P, Rai K, Sabina K, Kattel H, et al.
Trop Med Health
. 2022 Sep;
50(1):71.
PMID: 36131351
Introduction: Methicillin resistance, inducible clindamycin resistance (ICR), biofilm production, and increased minimum inhibitory concentration (MIC) of vancomycin in Staphylococcus aureus are major causes of antibiotic treatment failure and increased morbidity...
8.
Baidya S, Sharma S, Mishra S, Kattel H, Parajuli K, Sherchand J
Biomed Res Int
. 2021 Jun;
2021:8817700.
PMID: 34136573
Background: Emerging threat of drug resistance among pathogens causing ventilator-associated pneumonia (VAP) has resulted in higher hospital costs, longer hospital stays, and increased hospital mortality. Biofilms in the endotracheal tube...
9.
Acharya J, Zolfo M, Enbiale W, Kyaw K, Bhattachan M, Rijal N, et al.
Trop Med Infect Dis
. 2021 Apr;
6(2).
PMID: 33922405
Antimicrobial resistance (AMR) is a global problem, and Nepal is no exception. Countries are expected to report annually to the World Health Organization on their AMR surveillance progress through a...
10.
Mandal D, Sah S, Mishra S, Sharma S, Kattel H, Pandit S, et al.
Can J Infect Dis Med Microbiol
. 2020 Feb;
2020:5154217.
PMID: 32104519
Background: Extended-spectrum -lactamase (ESBL)- and AmpC--lactamase (ESBL)- and AmpC- have recently emerged as a public threat in the treatment of nosocomial as well as community-acquired infections. Very little information is...